Back to Search
Start Over
Cystic Fibrosis Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Genentech Inc., Novartis AG, Gilead Sciences Inc., Vertex Pharma
- Source :
- M2 Presswire. June 6, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PRESSWIRE-June 6, 2023-: Cystic Fibrosis Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Genentech Inc., Novartis AG, Gilead Sciences Inc., Vertex [...]
- Subjects :
- Allergan PLC -- Product development
Genentech Inc. -- Product development
Vertex Pharmaceuticals Inc. -- Product development
AbbVie Inc. -- Product development
Gilead Sciences Inc. -- Product development
Novartis AG -- Product development
Biological products industry -- Product development
Business -- Research
Medical research -- Reports
Medicine, Experimental -- Reports
Cystic fibrosis -- Reports
Biotechnology industry -- Product development
Clinical trials -- Reports
Pharmaceutical industry -- Product development
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.751975975